RESUMO
Single injection of Bacillus intermedius RNAase in a dose of 5 mg/kg could protect 40 and 50-70% of the outdoor rabies virus-preinfected guinea-pigs and rabbits, respectively. In the control group there were 100 and 75-100% deaths of the RNAase-untreated guinea-pigs and rabbits, respectively. Animal protection was observed only when RNAase was injected into the site of viral administration. The intramuscular injection of RNAase, other than the site of viral administration failed to protect the infected animals. The efficacy (75%) of RNAase injected into the rabbits was similar 1 and 24 hours after animal infection.
Assuntos
Bacillus/enzimologia , Proteínas de Bactérias/uso terapêutico , Vírus da Raiva , Raiva/tratamento farmacológico , Ribonucleases/uso terapêutico , Animais , Proteínas de Bactérias/administração & dosagem , Proteínas de Bactérias/farmacologia , Cobaias , Injeções Intramusculares , Coelhos , Raiva/prevenção & controle , Vírus da Raiva/efeitos dos fármacos , Ribonucleases/administração & dosagem , Ribonucleases/farmacologia , Fatores de TempoRESUMO
RNAse Bacillus intermedius, when administered once and according to 11 repeated experiments, protected the preliminarily infected CBA mice with street rabies virus (protection of 40-67%; p < 0.01-0.001). A reliable protection of Animals was registered only when RNAse was administered intramuscularly at the virus introduction spot; it was not effective, when the bacterial RNAse was injected in the brain, vein, under the skin or in muscles of a non-infected extremity. Neither did it produce any suppressive effect on the vaccinal antirabic immunity.
Assuntos
Antivirais/farmacologia , Bacillus/enzimologia , Vírus da Raiva/efeitos dos fármacos , Raiva/prevenção & controle , Ribonucleases/farmacologia , Animais , Antivirais/administração & dosagem , Imunidade Ativa/efeitos dos fármacos , Imunização , Injeções Intramusculares , Camundongos , Camundongos Endogâmicos CBA , Testes de Neutralização , Raiva/imunologia , Raiva/terapia , Vacina Antirrábica/administração & dosagem , Ribonucleases/administração & dosagemRESUMO
Anti-influenzal action of bacterial and pancreatic RNAases was studied. It was shown in ovo that the RNAases had distinct virus inhibiting activity with respect to various strains of the grippe A virus and did not practically differ by their activity from remantadin but unlike it had inhibitory action on the grippe B virus. The anti-influenzal activity of bacterial RNAase in contrast to pancreatic one was detected not only in experiments with developing chick embryos but also in albino mice with lethal influenzal infection. The index of the animal protection by the preparation amounted to 54-90 per cent depending on the virus infecting dose and RNAase administration route, the lifespan of the animals being increased by 2.4 to 3.8 days. It was shown that the anti-influenzal effect of bacterial RNAase correlated with high levels of the exogenic enzyme in blood of the animals after the preparation intravenous administration. Elimination of RNAase was observed already within the first 4 hours after the experiment start. Intranasal administration allowed to increase the residence time of RNAase in blood up to 8 hours at the account of its gradual absorption from the administration site and the preparation availability increased more than 2-fold. The results provided the basis for recommending the intranasal route of bacterial RNAase administration for use in further investigation of RNAase antiviral activity.